Biblio

56 Ergebnisse exportiert:
[ Autor(Desc)] Titel Typ Jahr
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
J
Jeltsch M, Tammela T, Alitalo K, Wilting J. Genesis and pathogenesis of lymphatic vessels. Cell Tissue Res [Internet]. 2003;314(1):69 - 84. http://view.ncbi.nlm.nih.gov/pubmed/12942362PDF Icon Michael Jeltsch et al., Cell and Tissue Research 2003 (562.33 KB)
Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, u. a.. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science (80- ) [Internet]. 1997;276(5317):1423 - 5. http://view.ncbi.nlm.nih.gov/pubmed/9162011PDF Icon Michael Jeltsch et al., Science 1997 (293.65 KB)
Jeltsch M. VEGFR-3 Ligands and Lymphangiogenesis [Internet]. University of Helsinki. 2002. http://ethesis.helsinki.fi/julkaisut/mat/bioti/vk/jeltschPDF Icon Michael Jeltsch, PhD Thesis, 2002 (1.75 MB)
Jeltsch M, Karpanen T, Strandin T, Aho K, Lankinen H, Alitalo K. Vascular endothelial growth factor (VEGF)/VEGF-C mosaic molecules reveal specificity determinants and feature novel receptor binding patterns. J Biol Chem [Internet]. 2006;281(17):12187 - 95. http://view.ncbi.nlm.nih.gov/pubmed/16505489PDF Icon Michael Jeltsch et al., The Journal of Biological Chemistry 2006 (1.04 MB)PDF Icon Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 1 (1.01 MB)PDF Icon Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 2 (596.06 KB)PDF Icon Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 3 (738.98 KB)PDF Icon Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 4 (710.03 KB)PDF Icon Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 5 (163.64 KB)
Jeltsch M. Drug-induced lymphangiogenesis. In 3. Schweizer Lymphsymposium [Internet]. Juzo; 2021. https://doi.org/10.5281/zenodo.6034307PDF Icon Jeltsch - 2021 - Drug-induced lymphangiogenesis (1.9 MB)
Jeltsch M. What you should know about VEGF-C when working with lymphatics [German]. In Lymphologie 2017 [Internet]. Bad Soden (Frankfurt), Germany; 2017. https://jeltsch.org/Abstrakt-BadSoden2017PDF Icon Extended Abstract (published in Vasomed, 2018) (226.5 KB)
Jeltsch M, Alitalo K. Lymphatic-to-blood vessel transdifferentiation in zebrafish. Nature Cardiovascular Research [Internet]. 2022;1(6):539 - 541. https://rdcu.be/cOjJ0
Jha SK, Rauniyar K, Chronowska E, Mattonet K, Maina EW, Koistinen H, u. a.. KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D. eLife [Internet]. 2019;8:e44478. https://elifesciences.org/articles/44478PDF Icon Jha & Rauniyar et al. 2019 (3.84 MB)
Jha SK. Mechanism of VEGF-C Activation and Effect on Lymphatic Vessel Growth and Regeneration [Internet]. [Helsinki, Finland]: University of Helsinki; 2020. https://helda.helsinki.fi/handle/10138/314714PDF Icon Jha - 2020 - Mechanism of VEGF-C Activation and Effect on Lymphatic Vessel Growth and Regeneration (1.96 MB)
Joukov V, Kaipainen A, Jeltsch M, Pajusola K, Olofsson B, Kumar V, u. a.. Vascular endothelial growth factors VEGF-B and VEGF-C. J Cell Physiol [Internet]. 1997;173(2):211 - 5. http://view.ncbi.nlm.nih.gov/pubmed/9365524PDF Icon Vladimir Joukov et al., Journal of Cellular Physiology 1997 (127.57 KB)
Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y, u. a.. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J [Internet]. 1997;16(13):3898 - 911. http://view.ncbi.nlm.nih.gov/pubmed/9233800PDF Icon Vladimir Joukov et al., EMBO Journal 1997 (729.21 KB)
Jussila L, Veikkola T, Jeltsch M, Thurston G, McDonald D, Achen M, u. a.. Signalling via VEGFR-3 is sufficient for lymphangiogenesis in transgenic mice. In Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications. Miami Beach, Florida; 2001. PDF Icon Jussila et al., 2001 (279.47 KB)

Seiten